. Registre, , 2017.

R. Rein--picardie, Agence de la biomédecine, 2016.

R. Amerling, C. Ronco, M. Kuhlman, and J. F. Winchester, Arteriovenous Fistula Toxicity, Blood Purif, vol.31, issue.1-3, pp.113-133, 2011.

C. Lomonte, C. Basile, S. Mitra, C. Combe, A. Covic et al., Should a fistula first policy be revisited in elderly haemodialysis patients? Nephrology Dialysis Transplantation, vol.17, 2018.

, United States Renal Data System, Annual Data Report, vol.3, p.18, 2018.

I. J. Arhuidese, M. A. Cooper, M. Rizwan, B. Nejim, and M. B. Malas, Vascular access for hemodialysis in the elderly, Journal of Vascular Surgery. févr, vol.69, issue.2, pp.517-525, 2019.

R. L. Pisoni, C. J. Arrington, J. M. Albert, J. Ethier, N. Kimata et al., Facility Hemodialysis Vascular Access Use and Mortality in Countries Participating in DOPPS: An Instrumental Variable Analysis, American Journal of Kidney Diseases. mars, vol.53, issue.3, pp.475-91, 2009.

B. D. Bray, J. Boyd, C. Daly, K. Donaldson, A. Doyle et al., Vascular access type and risk of mortality in a national prospective cohort of haemodialysis patients, QJM, vol.105, issue.11, pp.1097-103, 2012.

L. M. Miller, J. M. Macrae, M. Kiaii, E. Clark, C. Dipchand et al., Hemodialysis Tunneled Catheter Noninfectious Complications, Can J Kidney Health Dis. 26 sept, vol.3, p.205435811666913, 2016.

E. Lacson, W. Wang, J. M. Lazarus, and R. M. Hakim, Change in Vascular Access and Hospitalization Risk in Long-Term Hemodialysis Patients, Clin J Am Soc Nephrol, vol.5, issue.11, pp.1996-2003, 2010.

N. R. Powe, B. Jaar, S. L. Furth, J. Hermann, and W. Briggs, Septicemia in dialysis patients: Incidence, risk factors, and prognosis, Kidney International. mars, vol.55, issue.3, pp.1081-90, 1999.

M. J. Sarnak and B. L. Jaber, Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney International, vol.58, pp.1758-64, 2000.

A. J. Collins, R. N. Foley, C. Herzog, B. Chavers, D. Gilbertson et al., United States Renal Data System, Annual Data Report Abstract. American Journal of Kidney Diseases. janv, vol.53, issue.1, pp.6-7, 2008.

D. B. Nguyen, A. Shugart, C. Lines, A. B. Shah, J. Edwards et al., National Healthcare Safety Network (NHSN) Dialysis Event Surveillance Report for 2014, Clin J Am Soc Nephrol. 7 juill, vol.12, issue.7, pp.1139-1185, 2017.

P. Ravani, S. C. Palmer, M. J. Oliver, R. R. Quinn, J. M. Macrae et al., Associations between Hemodialysis Access Type and Clinical Outcomes: A Systematic Review, J Am Soc Nephrol. mars, vol.24, issue.3, pp.465-73, 2013.

K. E. Nelveg-kristensen, G. H. Laier, and J. G. Heaf, Risk of death after first-time blood stream infection in incident dialysis patients with specific consideration on vascular access and comorbidity, BMC Infect Dis. déc, vol.18, issue.1, p.688, 2018.

M. C. Weijmer, M. G. Vervloet, and P. M. Ter-wee, Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use, Nephrology Dialysis Transplantation. 1 mars, 2004.

, KDOQI Clinical Practice Guideline for Vascular Access, 2018.

Q. Pelletier, F. Joarder, M. Poutanen, S. M. Lok, and C. E. , Evaluating Approaches for the Diagnosis of Hemodialysis Catheter-Related Bloodstream Infections, Clin J Am Soc Nephrol. 6 mai, vol.11, issue.5, pp.847-54, 2016.

Y. Al-solaiman, E. Estrada, and M. Allon, The Spectrum of Infections in Catheter-Dependent Hemodialysis Patients, Clin J Am Soc Nephrol. sept, vol.6, issue.9, pp.2247-52, 2011.

D. L. Miller, O. Grady, and N. P. , Guidelines for the Prevention of Intravascular Catheter-related Infections: Recommendations Relevant to Interventional Radiology for Venous Catheter Placement and Maintenance, Journal of Vascular and Interventional Radiology. août, vol.23, issue.8, pp.997-1007, 2012.

S. Aslam, Effect of antibacterials on biofilms, American Journal of Infection Control. déc, vol.36, issue.10, 2008.

A. M. Onder, J. Chandar, A. A. Billings, N. Simon, R. Diaz et al., Comparison of Early versus Late Use of Antibiotic Locks in the Treatment of Catheter-Related Bacteremia, Clin J Am Soc Nephrol. juill, vol.3, issue.4, pp.1048-56, 2008.

L. A. Mermel, What is the evidence for intraluminal colonization of hemodialysis catheters?, Kidney International. juill, vol.86, issue.1, pp.28-33, 2014.

R. Sullivan, V. Samuel, C. Le, M. Khan, I. Alexandraki et al., Hemodialysis Vascular Catheter-Related Bacteremia, The American Journal of the Medical Sciences. déc, vol.334, issue.6, pp.458-65, 2007.

G. A. Beathard and A. Urbanes, Reducing tunneled hemodialysis catheter morbidity: infection associated with tunneled hemodialysis catheters: infection associated with TDC. Seminars in Dialysis, vol.21, pp.528-566, 2008.

S. Izoard, L. Ayzac, J. Meynier, J. Seghezzi, B. Jolibois et al., Infections sur cathéters d'hémodialyse : variations du risque en fonction de la durée de cathétérisme. Néphrologie & Thérapeutique, vol.13, pp.463-472, 2017.

H. Yap, S. Pang, C. Tan, Y. Tan, N. Goh et al., Catheter-related complications and survival among incident hemodialysis patients in Singapore, J Vasc Access. nov, vol.19, issue.6, pp.602-610, 2018.

H. Mohamed, A. Ali, L. D. Browne, N. H. O'connell, L. Casserly et al., Determinants and outcomes of access-related blood-stream infections among Irish haemodialysis patients; a cohort study, BMC Nephrol. déc, vol.20, issue.1, p.68, 2019.

K. Wang, P. Wang, X. Liang, X. Lu, and Z. Liu, Epidemiology of haemodialysis catheter complications: a survey of 865 dialysis patients from 14 haemodialysis centres in Henan province in China, BMJ Open. nov, vol.5, issue.11, p.7136, 2015.

A. Martín-peña, R. L. Márquez, M. Guerrero, N. Espinosa, Y. Blanco et al., Tunneled Hemodialysis Catheter-Related Bloodstream Infections: A Prospective Multicenter Cohort Study from Spain, J Vasc Access. avr, vol.13, issue.2, pp.239-284, 2012.

S. Mandolfo, P. Acconcia, R. Bucci, B. Corradi, M. Farina et al., Hemodialysis Tunneled Central Venous Catheters: Five-Year Outcome Analysis, J Vasc Access, vol.15, issue.6, pp.461-466, 2014.

M. Fysaraki, G. Samonis, A. Valachis, E. Daphnis, D. E. Karageorgopoulos et al., Microbiological Features and Outcome of Bloodstream Infections in Patients Undergoing Hemodialysis, Int J Med Sci, vol.10, issue.12, pp.1632-1640, 2013.

F. Delistefani, M. Wallbach, G. A. Müller, M. J. Koziolek, and C. Grupp, Risk factors for catheter-related infections in patients receiving permanent dialysis catheter, BMC Nephrol. déc, vol.20, issue.1, p.199, 2019.

A. Krishnan, K. Irani, R. Swaminathan, and P. Boan, A retrospective study of tunnelled haemodialysis central lineassociated bloodstream infections, Journal of Chemotherapy. 3 avr, vol.31, issue.3, pp.132-138, 2019.

K. Poinen, R. R. Quinn, A. Clarke, P. Ravani, S. Hiremath et al., Complications From Tunneled Hemodialysis Catheters: A Canadian Observational Cohort Study, American Journal of Kidney Diseases. avr, vol.73, issue.4, pp.467-75, 2019.

C. Chazot, J. Gassia, D. Benedetto, A. Cesare, S. Ponce et al., Is there any survival advantage of obesity in Southern European haemodialysis patients?, Nephrol Dial Transplant. sept, vol.24, issue.9, pp.2871-2877, 2009.

S. D. Hwang, J. H. Lee, S. W. Lee, J. K. Kim, M. Kim et al., Risk of overhydration and low lean tissue index as measured using a body composition monitor in patients on hemodialysis: a systemic review and metaanalysis. Renal Failure, vol.40, pp.51-60, 2018.

L. A. Dossett, L. A. Dageforde, B. R. Swenson, R. Metzger, H. Bonatti et al., Obesity and site-specific nosocomial infection risk in the intensive care unit, Surg Infect (Larchmt). avr, vol.10, issue.2, pp.137-179, 2009.

J. Parienti, M. Thirion, B. Mégarbane, B. Souweine, A. Ouchikhe et al., Femoral vs Jugular Venous Catheterization and Risk of Nosocomial Events in Adults Requiring Acute Renal Replacement Therapy: A Randomized Controlled Trial, JAMA. 28 mai, vol.299, issue.20, p.2413, 2008.

B. I. Engstrom, J. J. Horvath, J. K. Stewart, R. H. Sydnor, M. J. Miller et al., Tunneled Internal Jugular Hemodialysis Catheters: Impact of Laterality and Tip Position on Catheter Dysfunction and Infection Rates, Journal of Vascular and Interventional Radiology. sept, vol.24, issue.9, pp.1295-302, 2013.

A. Falk, Use of the Femoral Vein as Insertion Site for Tunneled Hemodialysis Catheters, Journal of Vascular and Interventional Radiology. févr, vol.18, issue.2, pp.217-242, 2007.

T. M. Vesely, Central venous catheter tip position: a continuing controversy, J Vasc Interv Radiol. mai, vol.14, issue.5, pp.527-561, 2003.

J. R. Mehall, D. A. Saltzman, R. J. Jackson, and S. D. Smith, Fibrin sheath enhances central venous catheter infection, Crit Care Med, vol.30, issue.4, p.5, 2002.

R. Vanholder, B. Canaud, R. Fluck, M. Jadoul, L. Labriola et al., Diagnosis, prevention and treatment of haemodialysis catheter-related bloodstream infections (CRBSI): a position statement of European Renal Best Practice (ERBP), Clinical Kidney Journal. 1 juin, vol.3, issue.3, pp.234-280, 2010.

E. Clark, J. Kappel, J. Macrae, C. Dipchand, S. Hiremath et al., Practical Aspects of Nontunneled and Tunneled Hemodialysis Catheters, Can J Kidney Health Dis. 26 sept, vol.3, p.205435811666912, 2016.

I. D. Maya and M. Allon, Outcomes of tunneled femoral hemodialysis catheters: comparison with internal jugular vein catheters, Kidney Int. déc, vol.68, issue.6, pp.2886-2895, 2005.

G. X. Zaleski, B. Funaki, J. M. Lorenz, R. S. Garofalo, M. A. Moscatel et al., Experience with tunneled femoral hemodialysis catheters, American Journal of Roentgenology. févr, vol.172, issue.2, pp.493-499, 1999.

G. Guillermo-corpus, J. M. Ramos-gordillo, and J. C. Peña-rodríguez, Survival and Clinical Outcomes of Tunneled Central Jugular and Femoral Catheters in Prevalent Hemodialysis Patients, Blood Purif, vol.47, issue.1-3, pp.132-141, 2019.

X. Lemaire, M. Morena, and . Leray-moragu&eacute,

H. Henriet-viprey, D. Chenine, L. Defez-fougeron, and C. , Analysis of Risk Factors for Catheter-Related Bacteremia in 2000 Permanent Dual Catheters for Hemodialysis, Blood Purif, vol.28, issue.1, pp.21-29, 2009.

M. Murea, K. M. James, G. B. Russell, G. V. Byrum, J. E. Yates et al., Risk of Catheter-Related Bloodstream Infection in Elderly Patients on Hemodialysis, Clin J Am Soc Nephrol. 7 avr, vol.9, issue.4, pp.764-70, 2014.

G. Jean, B. Charra, C. Chazot, T. Vanel, J. C. Terrat et al., Risk Factor Analysis for Long-Term Tunneled Dialysis Catheter-Related Bacteremias, Nephron, vol.91, issue.3, pp.399-405, 2002.

A. Dufour and V. Candas, Ageing and thermal responses during passive heat exposure: sweating and sensory aspects, Eur J Appl Physiol. 12 avr, vol.100, issue.1, pp.19-26, 2007.

N. P. O'grady, A. M. Burns, L. A. Dellinger, E. P. Garland, J. Heard et al., Summary of Recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections, Clinical Infectious Diseases. 1 mai, vol.52, issue.9, pp.1087-99, 2011.

J. M. Ryan, B. M. Ryan, and T. P. Smith, Antibiotic prophylaxis in interventional radiology, J Vasc Interv Radiol. juin, vol.15, issue.6, pp.547-56, 2004.

S. Aslam, F. Vaida, M. Ritter, and R. L. Mehta, Systematic Review and Meta-Analysis on Management of Hemodialysis Catheter-Related Bacteremia, JASN. déc, vol.25, issue.12, pp.2927-2968, 2014.

L. M. Miller, E. Clark, C. Dipchand, S. Hiremath, J. Kappel et al., Hemodialysis Tunneled Catheter-Related Infections, Can J Kidney Health Dis. 26 sept, vol.3, p.205435811666912, 2016.

C. E. Lok and M. H. Mokrzycki, Prevention and management of catheter-related infection in hemodialysis patients, Kidney International. mars, vol.79, issue.6, pp.587-98, 2011.

S. Maraj, L. E. Jacobs, M. N. Kotler, S. Kung, R. Raja et al., Epidemiology and Outcome of Infective Endocarditis in Hemodialysis Patients, The American Journal of the Medical Sciences, vol.324, issue.5, pp.254-60, 2002.

L. A. Mermel, M. Allon, E. Bouza, D. E. Craven, P. Flynn et al., Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America, Clin Infect Dis. juill, vol.49, issue.1, pp.1-45, 2009.

P. Ravani, B. W. Gillespie, R. R. Quinn, J. Macrae, B. Manns et al., Temporal Risk Profile for Infectious and Noninfectious Complications of Hemodialysis Access, JASN. oct, vol.24, issue.10, pp.1668-77, 2013.

M. Allon, Treatment Guidelines for Dialysis Catheter-Related Bacteremia: An Update, American Journal of Kidney Diseases. juill, vol.54, issue.1, pp.13-20, 2009.

T. S. Johns and M. H. Mokrzycki, Optimal Approach for the Diagnosis of Hemodialysis Catheter-Related Bacteremia, Clin J Am Soc Nephrol. 6 mai, vol.11, issue.5, pp.756-764, 2016.

L. Kumbar and J. Yee, Current Concepts in Hemodialysis Vascular Access Infections. Advances in Chronic Kidney Disease, janv, vol.26, issue.1, pp.16-22, 2019.

B. C. Camins, Prevention and Treatment of Hemodialysis-Related Bloodstream Infections, Semin Dial. juill, vol.26, issue.4, pp.476-81, 2013.

K. E. Chan, H. S. Warren, R. I. Thadhani, D. Steele, J. L. Hymes et al., Prevalence and Outcomes of Antimicrobial Treatment for Staphylococcus aureus Bacteremia in Outpatients with ESRD, JASN. sept, vol.23, issue.9, pp.1551-1560, 2012.

K. M. Krause, A. W. Serio, T. R. Kane, and L. E. Connolly, Aminoglycosides: An Overview. Cold Spring Harb Perspect Med, juin, vol.6, issue.6, p.27029, 2016.

K. L. Laplante and L. A. Mermel, In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model, Nephrology Dialysis Transplantation. 29 mars, vol.22, issue.8, pp.2239-2285, 2007.

I. Raad, H. Hanna, Y. Jiang, T. Dvorak, R. Reitzel et al., Comparative Activities of Daptomycin, Linezolid, and Tigecycline against Catheter-Related Methicillin-Resistant Staphylococcus Bacteremic Isolates Embedded in Biofilm, Antimicrobial Agents and Chemotherapy. 1 mai, vol.51, issue.5, pp.1656-60, 2007.

P. Tatarelli, A. Parisini, D. Bono, V. Mikulska, M. Viscoli et al., Efficacy of daptomycin lock therapy in the treatment of bloodstream infections related to long-term catheter, Infection. févr, vol.43, issue.1, pp.107-116, 2015.

H. Yen, Y. Tarng, D. , Y. Chuang, C. Huang et al., Daptomycin antibiotic lock therapy for hemodialysis patients with Gram-positive bloodstream infections following use of tunneled, cuffed hemodialysis catheters: retrospective single center analysis: Daptomycin ALT for G-positive BSIs, Hemodialysis International. avr, vol.20, issue.2, pp.315-335, 2016.

, Updates Clinical Practice Guidelines and Recommendations : Vascular access, 2006.

D. R. Ashby, A. Power, S. Singh, P. Choi, D. H. Taube et al., Bacteremia Associated with Tunneled Hemodialysis Catheters: Outcome after Attempted Salvage, Clin J Am Soc Nephrol, vol.4, issue.10, pp.1601-1606, 2009.

M. H. Mokrzycki, M. Zhang, H. Cohen, L. Golestaneh, J. M. Laut et al., Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality, Nephrology Dialysis Transplantation. 1 avr, vol.21, issue.4, pp.1024-1055, 2006.

H. M. Saleh, M. M. Tawfik, and H. Abouellail, Prospective, randomized study of long-term hemodialysis catheter removal versus guidewire exchange to treat catheter-related bloodstream infection, Journal of Vascular Surgery, vol.66, issue.5, pp.1427-1431, 2017.

A. J. Joshi and P. D. Hart, Antibiotic Catheter Locks in the Treatment of Tunneled Hemodialysis Catheter-Related Blood Stream Infection: Antibiotic locks for dialysis catheter infections, Seminars in Dialysis. mars, vol.26, issue.2, pp.223-229, 2013.

Z. Krishnasami, D. Carlton, L. Bimbo, M. E. Taylor, D. F. Balkovetz et al., Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution, Kidney International. mars, vol.61, issue.3, pp.1136-1178, 2002.

C. V. Poole, D. Carlton, L. Bimbo, and M. Allon, Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen, Nephrology Dialysis Transplantation. 1 mai, vol.19, issue.5, pp.1237-1281, 2004.

I. D. Maya, D. Carlton, E. Estrada, and M. Allon, Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report, Am J Kidney Dis. août, vol.50, issue.2, pp.289-95, 2007.

A. M. Onder, A. Billings, J. Chandar, D. Francoeur, N. Simon et al., PREFABL: predictors of failure of antibiotic locks for the treatment of catheter-related bacteraemia, Nephrol Dial Transplant, vol.25, issue.11, pp.3686-93, 2010.

A. M. Onder, A. A. Billings, J. Chandar, L. Nield, D. Francoeur et al., Antibiotic lock solutions allow less systemic antibiotic exposure and less catheter malfunction without adversely affecting antimicrobial resistance patterns: ABL improves antibiotic exposure, Hemodial Int. janv, vol.17, issue.1, pp.75-85, 2013.

A. M. Onder, J. Chandar, N. Simon, M. Saint-vil, D. Francoeur et al., Treatment of catheter-related bacteremia with tissue plasminogen activator antibiotic locks, Pediatr Nephrol. mars, vol.23, issue.3, pp.457-64, 2008.

A. M. Onder, J. Chandar, N. Simon, R. Diaz, O. Nwobi et al., Comparison of tissue plasminogen activator-antibiotic locks with heparin-antibiotic locks in children with catheter-related bacteraemia, Nephrology Dialysis Transplantation. 2 avr, vol.23, issue.8, pp.2604-2614, 2008.

L. Labriola, Antibiotic locks for the treatment of catheter-related blood stream infection: Still more hope than data, Semin Dial. sept, vol.32, issue.5, pp.402-407, 2019.

D. G. Maki, C. J. Alvarado, and M. Ringer, Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters, The Lancet. août, vol.338, issue.8763, pp.339-382, 1991.

N. M. Lai, N. A. Lai, E. O'riordan, N. Chaiyakunapruk, J. E. Taylor et al., Skin antisepsis for reducing central venous catheter-related infections, Cochrane Database of Systematic Reviews, vol.13, 2016.

O. Mimoz, J. Lucet, T. Kerforne, J. Pascal, B. Souweine et al., Skin antisepsis with chlorhexidinealcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascularcatheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial. The Lancet, vol.386, pp.2069-77, 2015.

M. D. Broucker, B. Décaudin, S. Dewulf, J. P. Resibois, F. Danicourt-barrier et al., Incompatibilité physico-chimique entre polyéthylène glycol et cathéters centraux d'hémodialyse en polyuréthane, vol.26, p.4, 2007.

S. R. Ash, The evolution and function of central venous catheters for dialysis, Semin Dial. déc, vol.14, issue.6, pp.416-440, 2001.

S. A. Mcconnell, P. O. Gubbins, and E. J. Anaissie, Do Antimicrobial-Impregnated Central Venous Catheters Prevent Catheter-Related Bloodstream Infection?, Clinical Infectious Diseases. 1 juill, vol.37, issue.1, pp.65-72, 2003.

I. W. Apata, J. Hanfelt, J. L. Bailey, and V. D. Niyyar, Chlorhexidine-impregnated transparent dressings decrease catheter-related infections in hemodialysis patients: a quality improvement project, J Vasc Access. mars, vol.18, issue.2, pp.103-111, 2017.

M. Righetti, N. Palmieri, O. Bracchi, M. Prencipe, E. Bruschetta et al., Tegaderm TM CHG Dressing Significantly Improves Catheter-related Infection Rate in Hemodialysis Patients, J Vasc Access. sept, vol.17, issue.5, pp.417-439, 2016.

L. Wei, Y. Li, X. Li, L. Bian, Z. Wen et al., Chlorhexidine-impregnated dressing for the prophylaxis of central venous catheter-related complications: a systematic review and meta-analysis, BMC Infect Dis. déc, vol.19, issue.1, p.429, 2019.

H. F. Wertheim, D. C. Melles, M. C. Vos, W. Van-leeuwen, A. Van-belkum et al., The role of nasal carriage in Staphylococcus aureus infections, The Lancet Infectious Diseases. déc, vol.5, issue.12, pp.751-62, 2005.

M. Scheuch, S. Freiin-von-rheinbaben, A. Kabisch, J. Engeßer, S. Ahrendt et al., Staphylococcus aureus colonization in hemodialysis patients: a prospective 25 months observational study, BMC Nephrol. déc, vol.20, issue.1, p.153, 2019.

H. F. Wertheim, M. C. Vos, A. Ott, A. Van-belkum, A. Voss et al., Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers, The Lancet. août, vol.364, issue.9435, pp.703-708, 2004.

D. W. Johnson, A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters, Nephrology Dialysis Transplantation, vol.17, issue.10, pp.1802-1809, 2002.

E. Tacconelli, Y. Carmeli, A. Aizer, G. Ferreira, M. G. Foreman et al., Mupirocin Prophylaxis to Prevent Staphylococcus aureus Infection in Patients Undergoing Dialysis: A Meta-analysis, Clinical Infectious Diseases. 15 déc, vol.37, issue.12, pp.1629-1667, 2003.

M. S. Rudresh, G. S. Ravi, A. Motagi, A. M. Alex, P. Sandhya et al., Prevalence of mupirocin resistance among staphylococci, its clinical significance and relationship to clinical use, J Lab Physicians. déc, vol.7, issue.2, pp.103-110, 2015.

D. J. Hetem and M. Bonten, Clinical relevance of mupirocin resistance in Staphylococcus aureus, Journal of Hospital Infection. déc, vol.85, issue.4, pp.249-56, 2013.

T. Shimohata, K. Mawatari, T. Uebanso, A. Honjo, A. Tsunedomi et al., Bacterial contamination of hemodialysis devices in hospital dialysis wards, J Med Invest, vol.66, issue.1, pp.148-52, 2019.

, Circulaire DHOS/SDO n° 228 du 15 mai 2003 relative à l'application des décrets, 1197.

, Circulaire DHOS/O1 n o 2005-205 du 25 avril 2005 relative aux locaux, matériels techniques et dispositifs médicaux dans les établissements de santé exerçant l'activité «

J. E. Moran and S. R. Ash, the Clinical Practice Committee. Locking Solutions for Hemodialysis Catheters

C. Heparin, Position Paper by ASDIN: locking solutions for hemodialysis catheters, Seminars in Dialysis. 31 août, vol.21, issue.5, pp.490-492, 2008.

A. Davenport, Review article: Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments, Nephrology. août, vol.14, issue.5, pp.455-61, 2009.

B. R. Hemmelgarn, L. M. Moist, C. E. Lok, M. Tonelli, B. J. Manns et al., Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator, N Engl J Med. 27 janv, vol.364, issue.4, pp.303-315, 2011.

-. Food and D. Administration, FDA Issues Warning on Tricitrasol Dialysis Catheter Anticoagulant. FDA Talk Paper TOO-16 14, 2000.

Y. Zhao, Z. Li, L. Zhang, J. Yang, Y. Yang et al., Citrate Versus Heparin Lock for Hemodialysis Catheters: A Systematic Review and Meta-analysis of Randomized Controlled Trials, American Journal of Kidney Diseases. mars, vol.63, issue.3, pp.479-90, 2014.

H. Mai, Y. Zhao, S. Salerno, Y. Li, Y. Feng et al., Citrate versus heparin lock for prevention of hemodialysis catheter-related complications: updated systematic review and meta-analysis of randomized controlled trials, Int Urol Nephrol. juin, vol.51, issue.6, pp.1019-1052, 2019.

J. W. Bosma, C. Siegert, P. Peerbooms, and M. C. Weijmer, Reduction of biofilm formation with trisodium citrate in haemodialysis catheters: a randomized controlled trial, Nephrology Dialysis Transplantation. 1 avr, vol.25, issue.4, pp.1213-1220, 2010.

C. Torres-viera, C. Thauvin-eliopoulos, M. Souli, P. Degirolami, M. G. Farris et al., Activities of Taurolidine In Vitro and in Experimental Enterococcal Endocarditis, Antimicrobial Agents and Chemotherapy. 1 juin, vol.44, issue.6, pp.1720-1724, 2000.

L. R. Solomon, J. S. Cheesbrough, L. Ebah, T. Al-sayed, M. Heap et al., A Randomized Double-Blind Controlled Trial of Taurolidine-Citrate Catheter Locks for the Prevention of Bacteremia in Patients Treated With Hemodialysis, American Journal of Kidney Diseases. juin, vol.55, issue.6, pp.1060-1068, 2010.

L. R. Solomon, J. S. Cheesbrough, R. Bhargava, N. Mitsides, M. Heap et al., Observational Study of Need for Thrombolytic Therapy and Incidence of Bacteremia using Taurolidine-Citrate-Heparin, Taurolidine-Citrate and Heparin Catheter Locks in Patients Treated with Hemodialysis: taurolidine-citrate-heparin, taurolidine-citrate and heparin catheter locks, Seminars in Dialysis. mars, vol.25, issue.2, pp.233-241, 2012.

W. Winnicki, H. Herkner, M. Lorenz, A. Handisurya, ?. Kiki? et al., Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters, Kidney International. mars, vol.93, issue.3, pp.753-60, 2018.

H. Liu, H. Liu, J. Deng, L. Chen, L. Yuan et al., Preventing Catheter-Related Bacteremia with Taurolidine-Citrate Catheter Locks: A Systematic Review and Meta-Analysis, Blood Purif, vol.37, issue.3, pp.179-87, 2014.

R. Zwiech, M. Adelt, and S. Chrul, A Taurolidine-Citrate-Heparin Lock Solution Effectively Eradicates Pathogens From the Catheter Biofilm in Hemodialysis Patients, American Journal of Therapeutics, vol.23, issue.2, pp.363-371, 2016.

A. Hamdy, A. F. Hamad, A. Elsayed, M. , Z. Iqbal et al., Safety and efficacy of taurolidine/urokinase versus taurolidine/heparin as a tunneled catheter lock solution in hemodialysis patients: a prospective, randomized, controlled study, Nephrology Dialysis Transplantation. 1 avr, vol.33, issue.4, pp.619-645, 2018.

L. Labriola and M. Jadoul, Taurolidine-based lock solutions for hemodialysis catheters: the enthusiasm should be tempered, Kidney International. avr, vol.93, issue.4, pp.1015-1021, 2018.

D. Yahav, B. Rozen-zvi, A. Gafter-gvili, L. Leibovici, U. Gafter et al., Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials, Clin Infect Dis. 1 juill, vol.47, issue.1, pp.83-93, 2008.

C. L. Moore, A. Besarab, M. Ajluni, V. Soi, E. L. Peterson et al., Comparative Effectiveness of Two Catheter Locking Solutions to Reduce Catheter-Related Bloodstream Infection in Hemodialysis Patients, Clin J Am Soc Nephrol. 7 juill, vol.9, issue.7, pp.1232-1241, 2014.

D. L. Landry, G. L. Braden, S. L. Gobeille, S. D. Haessler, C. K. Vaidya et al., Emergence of Gentamicin-Resistant Bacteremia in Hemodialysis Patients Receiving Gentamicin Lock Catheter Prophylaxis, Clin J Am Soc Nephrol, vol.5, issue.10, pp.1799-804, 2010.

T. Bueloni, D. Marchi, C. Caetano, R. De-souza-cavalcante, M. Amaral et al., Cefazolingentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial, International Journal of Infectious Diseases. août, vol.85, pp.16-21, 2019.

T. Zhao, H. Liu, and J. Han, Ethanol lock is effective on reducing the incidence of tunneled catheter-related bloodstream infections in hemodialysis patients: a systematic review and meta-analysis, Int Urol Nephrol. sept, vol.50, issue.9, pp.1643-52, 2018.

G. Schilcher, A. Schlagenhauf, D. Schneditz, H. Scharnagl, W. Ribitsch et al., Ethanol Causes Protein Precipitation-New Safety Issues for Catheter Locking Techniques. Beloin C, éditeur, PLoS ONE. 31 déc, vol.8, issue.12, p.84869, 2013.

L. M. Vercaigne, D. R. Allan, S. W. Armstrong, J. M. Zacharias, and L. M. Miller, An Ethanol/Sodium Citrate Locking Solution Compared to Heparin to Prevent Hemodialysis Catheter-Related Infections: a Randomized Pilot Study, J Vasc Access. janv, vol.17, issue.1, pp.55-62, 2016.

M. Tan, J. Lau, and B. J. Guglielmo, Ethanol Locks in the Prevention and Treatment of Catheter-Related Bloodstream Infections, Ann Pharmacother. mai, vol.48, issue.5, pp.607-622, 2014.

A. S. El-hennawy, E. Frolova, and W. A. Romney, Sodium bicarbonate catheter lock solution reduces hemodialysis catheter loss due to catheter-related thrombosis and bloodstream infection: an open-label clinical trial, Nephrol Dial Transplant. 21 janv, 2019.

D. G. Maki, S. R. Ash, R. K. Winger, and P. Lavin, A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: A multi-center, controlled, randomized trial: Critical Care Medicine, avr, vol.39, issue.4, pp.613-633, 2011.

V. Ramanathan, E. J. Chiu, J. T. Thomas, A. Khan, G. M. Dolson et al., Healthcare Costs Associated with Hemodialysis Catheter-Related Infections: A Single-Center Experience, Infect Control Hosp Epidemiol. mai, vol.28, issue.05, pp.606-615, 2007.

S. Mandolfo, M. Maggio, G. Forneris, and F. Galli, Cost analysis of haemodialysis catheter related bloodstream infection through the DRG system, « on behalf of Project Group of Vascular Access of Italian Society of Nephrology

, G Ital Nefrol. févr, vol.36, issue.1, 2019.

M. H. Mokrzycki, Cost-effectiveness of three strategies of managing tunnelled, cuffed haemodialysis catheters in clinically mild or asymptomatic bacteraemias, Nephrology Dialysis Transplantation. 1 déc, vol.17, issue.12, pp.2196-203, 2002.

S. D. Kosa and C. E. Lok, The Economics of Hemodialysis Catheter-Related Infection Prophylaxis, Semin Dial. juill, vol.26, issue.4, pp.482-93, 2013.

D. Réseau, Surveillance des infections des voies d'abord vasculaires en hémodialyse, 2017.

S. Brunelli, L. Njord, A. Hunt, and S. Sibbel, Use of the Tego needlefree connector is associated with reduced incidence of catheter-related bloodstream infections in hemodialysis patients, IJNRD. avr, p.131, 2014.

J. L. Hymes, A. Mooney, C. Van-zandt, L. Lynch, R. Ziebol et al., Dialysis Catheter-Related Bloodstream Infections: A Cluster-Randomized Trial of the ClearGuard HD Antimicrobial Barrier Cap, American Journal of Kidney Diseases. févr, vol.69, issue.2, pp.220-227, 2017.

S. M. Brunelli, D. B. Van-wyck, L. Njord, R. J. Ziebol, L. E. Lynch et al., Cluster-Randomized Trial of Devices to Prevent Catheter-Related Bloodstream Infection, JASN. avr, vol.29, issue.4, pp.1336-1379, 2018.

P. Brañas, E. Morales, F. Ríos, F. Sanz, E. Gutiérrez et al., Usefulness of endoluminal catheter colonization surveillance cultures to reduce catheter-related bloodstream infections in hemodialysis, American Journal of Infection Control, vol.42, issue.11, pp.1182-1189, 2014.

P. D. Stamper, M. Cai, T. Howard, S. Speser, and K. C. Carroll, Clinical Validation of the Molecular BD GeneOhm StaphSR Assay for Direct Detection of Staphylococcus aureus and Methicillin-Resistant Staphylococcus aureus in Positive Blood Cultures, Journal of Clinical Microbiology. 1 juill, vol.45, issue.7, pp.2191-2197, 2007.

G. N. Forrest, PNA FISH: present and future impact on patient management, Expert Rev Mol Diagn. mai, vol.7, issue.3, pp.231-237, 2007.

H. Shinefield, S. Black, A. Fattom, G. Horwith, S. Rasgon et al., Use of a Staphylococcus aureus Conjugate Vaccine in Patients Receiving Hemodialysis, N Engl J Med. 14 févr, vol.346, issue.7, pp.491-497, 2002.

A. Fattom, A. Matalon, J. Buerkert, K. Taylor, S. Damaso et al., Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study, Human Vaccines & Immunotherapeutics. 4 mars, vol.11, issue.3, pp.632-673, 2015.

. Remerciements-madame-le-docteur-marianne-renou-praticien and . Hospitalier, Dialyse et Transplantation Merci beaucoup d'avoir dirigé cette thèse. C'est un honneur pour moi de t'avoir eu comme médecin référent en dialyse. Mille mercis pour ton encadrement, ta patience et tes connaissances transmises pendant mon internat. Merci également pour ton humanité

, Merci aux néphrologues d'Amiens et Beauvais, merci aux endocrinologues du CHB, merci aux cardiologues du CHB qui m'ont tant appris à leurs côtés !

, Merci à l'équipe de Caen qui m'a si bien accueillie pendant 6 mois : merci aux médecins, merci aux infirmiers de l'HDJ, merci à mes co-internes de néphrologie

C. Rémi, . Mathieu, . Amine, . Najib, . Malek et al., Merci aux amis que je vois moins souvent mais que je n'oublie pas ! Chacha, Merci à mes co-internes pour tous ces moments passés ensemble !! Je pense surtout à Alexandre

F. !!-coco, . Huguette, . Céline, . Edwige, A. Marion et al., Merci à mes co-équipières du volley qui me permettent de me défouler et de m'amuser